Bioextrax AB (publ.) OMXSTO:BIOEX:
SAID ON TUESDAY BIOEXTRAX AND CHEMATUR SIGN MOU WITH THIRD PARTY REGARDING PHBV PRODUCTION
THE CUSTOMER IS A JOINT VENTURE BETWEEN TWO CORPORATE GROUPS, WHICH TOGETHER HAVE A TURNOVER OF MORE THAN EUR 2.5 BILLION
THE MOU CONCERNS A LICENSE AGREEMENT FOR PRODUCTION UP TO 10,000 TONS OF PHBV/YEAR
THE MOU IS A NON-BINDING LETTER OF INTENT AND IS EXPECTED TO BE REPLACED BY A BINDING AGREEMENT BY FEBRUARY 2026
THE TOTAL REVENUE POTENTIAL FOR BIOEXTRAX UPON FULL IMPLEMENTATION OF THE PROJECT AMOUNTS TO APPROXIMATELY EUR 3.4 MILLION
Source text for Workspace:
Further company coverage: